About
Paul Thurk is a Managing Director with ARCH Venture Partners. Mr. Thurk joined ARCH in 2000 from SSM Ventures, via a two-year Kauffman Fellowship with the Partnership. He focuses on solid-state lighting, semiconductors, advanced materials, nanotechnology, electronics and optoelectronics. Mr. Thurk has also been a key part of ARCH’s efforts at Los Alamos National Laboratory and at Sandia National Laboratories in their entrepreneur-in-residence program with the U.S. Department of Energy. He recently established ARCH’s Dublin, Ireland office to assess European-sourced technology and investment opportunities. Mr. Thurk was co-founder and initial CEO of Innovalight (acquired by DuPont-DD) and CoolEdge Lighting. He has participated in the development of ARCH portfolio companies Kotura (acquired by Mellanox), Nitronex (acquired by MACOM), Cambrios, and Semprius. He co-founded Carrick Therapeutics and Genomics Medicine Ireland, and serves as a Director of both companies, and is a board obser
Position in the VCSift Database
- • 6 investors at ARCH Venture Partners are tracked.
- • 2 investors hold the Managing Director Europe role in VCSift. Paul Thurk is one of them.
- • 28 investors are based in Dublin, Ireland.
Data sourced from 410,343 investor profiles. Updated June 2026.
Investment Focus
- Location
- Dublin, Ireland
Contact Information
Find more investors like Paul
Search Investors